Early Access Opportunity:
Beginning August 18, 2020
ONS Bridge Launch:
Tuesday, September 8, 2020
5:00 – 6:30 PM ET
Support:
This activity is supported by educational grants from Bristol Myers Squibb (formerly Celgene); Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC; Karyopharm Therapeutics Inc.; Oncopeptides, Inc.; and Takeda Oncology.